Investing in ANI Pharmaceuticals, Inc. (ANIP)  ➔  Intrinsic value

Prev. close$33.56 
ModelValueUpside
Chepakovich$3.08-91%
Graham-Dodd$0.00-100%
Graham$0.00-100%
Previous Close$33.56  
Valuation MethodValuePotential 
Chepakovich Model$3.08-91%recalculate
Graham-Dodd$0.00-100%recalculate
Graham Formula$0.00-100%recalculate

Latest news

7 May

ANI Pharmaceuticals Inc (ANIP) Q1 2021 Earnings Call Transcript => Motley Fool 11:30AM

ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Top Estimates => Zacks 8:05AM

ANI Pharmaceuticals Reports First Quarter 2021 Results => Business Wire 6:50AM

ANI Pharmaceuticals, Inc. to Host Earnings Call => ACCESSWIRE 6:45AM

30 Apr

Earnings Preview: ANI Pharmaceuticals (ANIP) Q1 Earnings Expected to Decline => Zacks 3:00PM

27 Apr

ANI Pharmaceuticals, Inc. -- Moody's assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stable => Moody's 1:41PM

26 Apr

ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021 => Business Wire 4:30PM

6 Apr

ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs => Business Wire 6:50AM

22 Mar

ANI Pharmaceuticals (ANIP) Enters Overbought Territory => Zacks 6:27AM

9 Mar

ANI Pharmaceuticals Inc (ANIP) Q4 2020 Earnings Call Transcript => Motley Fool 1:00PM

ANI Pharmaceuticals (ANIP) Q4 Earnings Miss Estimates => Zacks 8:05AM

ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth => Business Wire 6:50AM

ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business => Business Wire 6:45AM

ANI Pharmaceuticals, Inc. to Host Earnings Call => ACCESSWIRE 5:30AM

8 Mar

ANI Pharmaceuticals's Earnings: A Preview => Benzinga 10:18AM

7 Mar

What Type Of Shareholders Make Up ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Share Registry? => Simply Wall St. 1:25AM

2 Mar

Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to Decline => Zacks 12:30PM

19 Feb

ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) => Business Wire 4:30PM

17 Feb

ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth => Business Wire 6:50AM

16 Feb

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021 => Business Wire 4:30PM

1 Feb

ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride ("HCl") Capsules => Business Wire 6:50AM

6 Jan

ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 54% On Their Shares => Simply Wall St. 12:13AM

17 Dec

ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets => Business Wire 6:50AM

3 Dec

Is ANI Pharmaceuticals (ANIP) A Good Stock To Buy Now? => Insider Monkey 9:50PM

17 Nov

Should Value Investors Pick ANI Pharmaceuticals (ANIP) Now? => Zacks 10:32AM

7 Nov

Should You Take Comfort From Insider Transactions At ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)? => Simply Wall St. 7:44AM

5 Nov

ANI Pharmaceuticals Inc (ANIP) Q3 2020 Earnings Call Transcript => Motley Fool 4:01PM

ANI Pharmaceuticals Reports Third Quarter 2020 Results => Business Wire 6:50AM

29 Oct

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results => Business Wire 6:50AM

28 Oct

Analysts Estimate ANI Pharmaceuticals (ANIP) to Report a Decline in Earnings: What to Look Out for => Zacks 12:32PM

10 Sep

ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) => Business Wire 7:00PM

6 Aug

ANI Pharmaceuticals (ANIP) Q2 Earnings Miss Estimates => Zacks 8:35AM

ANI Pharmaceuticals Reports Second Quarter 2020 Results => Business Wire 6:50AM

ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors => Business Wire 6:45AM

3 Aug

ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer => Business Wire 6:50AM

30 Jul

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results => Business Wire 6:50AM

29 Jul

Earnings Preview: ANI Pharmaceuticals (ANIP) Q2 Earnings Expected to Decline => Zacks 12:33PM

8 Jul

New Strong Sell Stocks for July 8th => Zacks 7:38AM

4 Jul

Hedge Funds Are Selling ANI Pharmaceuticals Inc (ANIP) => Insider Monkey 8:54PM

30 Jun

ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules => PR Newswire 8:30AM

Company description

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncolytics (anti-cancers), hormones and steroids, and other formulations. The company offers pharmaceuticals for the treatment of breast cancer, hypertension, ventricular arrhythmias, stage D2 metastatic carcinoma of the prostate, depression, diarrhea, infections, vasomotor symptoms of menopause, pain caused by osteoarthritis and rheumatoid arthritis, epilepsy, arrhythmia, obsessive-compulsive disorder and social anxiety disorder, ulcerative colitis, salt and fluid retention, manic episodes of bipolar disorder, ulcerative colitis, proctosigmoiditis, ocular conditions, metastatic prostate cancer, arrhythmia, migraine headache, and enterocolitis caused by staphylococcus aureus. It also provides aspirin and extended-release dipyridamole; Cholestyramine, an adjunctive therapy to diet for the reduction of elevated serum cholesterol; Ezetimibe-Simvastatin to lower high cholesterol and triglyceride levels; Fenofibrate, a peroxisome proliferator receptor alpha activator; Hydrocortisone rectal cream for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Morphine Sulfate, an oral solution for acute and chronic pain management; Nimodipine to enhance neurological outcomes; and Terbutaline Sulfate for the prevention and reversal of bronchospasm. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.